for active and intelligent packaging is forecast to climb 8.0 percent annually
to $2.3 billion in 2015, significantly outpacing overall packaging demand. Advances will be driven by the availability
of products with more reasonable price points and those offering enhanced shelf
life and/or improved quality.
Additionally, gains will be supported by new mandates aimed at improving
food safety and by the leveraging of smartphone applications to bring
interactivity to packaging. These and
other trends, including market share and product segmentation, are presented in
& Intelligent Packaging, a new study from The Freedonia
Group, Inc., a Cleveland-based industry market research firm.
for intelligent packaging is expected to expand at nearly 20 percent annually
to $370 million in 2015, propelled by rapid growth for Quick
Response (QR) and other two-dimensional (2D) barcodes. Demand will also be fueled by greater use of
time-temperature indicator (TTI) labels and tags due to the increased presence
of temperature-sensitive drugs and new regulations calling for increased track
and trace capabilities with perishable foods.
for active packaging is projected to increase 6.5 percent per year to $1.9
billion in 2015.
Gains will be driven by above-average advances for gas scavengers, the
result of expanded applications for oxygen scavengers in food, beverage and
pharmaceutical packaging. Additionally,
growth will be propelled by solid prospects for susceptor packaging in
applications other than microwave popcorn and robust increases for self-venting
and beverages were the two largest markets for active and intelligent packaging
in 2010. Above-average
gains in food uses will be based on heightened requirements for longer shelf
life for processed foods and packaged fresh foods containing fewer or no
preservatives. Moreover, opportunities
will reflect the need for enhanced tracking and tracing capabilities with
perishables in light of the passage of the Food Safety Modernization Act of
January 2011. The pharmaceutical market is expected to post the fastest growth
through 2015, driven by the health care needs of the aging US population,
along with the increasing presence of high-value, temperature-sensitive
biotechnology drugs in the product mix.
Group is a leading international business
research company, founded in 1985, that publishes more than 100 industry
research studies annually. This industry analysis provides an unbiased outlook
and a reliable assessment of an industry and includes product
segmentation and demand forecasts, industry trends, demand history, threats
and opportunities, competitive strategies, market share determinations and